News headlines about Varian Medical Systems (NYSE:VAR) have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Varian Medical Systems earned a daily sentiment score of 0.21 on Accern’s scale. Accern also gave media coverage about the medical equipment provider an impact score of 44.7605297547129 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
These are some of the news stories that may have impacted Accern’s scoring:
- Varian Medical Systems, Inc. (NYSE:VAR) – Market Cap Evaluation – Nasdaq Journal (nasdaqjournal.com)
- Varian Medical Systems, Inc. (VAR) stock is now worth at $125.49 while Analyst mean rating stands at 2.50 – Nasdaq Fortune (press release) (nasdaqfortune.com)
- Varian Medical Systems (VAR) Upgraded to Buy by Zacks Investment Research (americanbankingnews.com)
- 5 Jefferies Growth Stocks to Buy Have Big Upside Potential (msn.com)
- Varian (VAR) to Equip 7 Centers in Mexico, Expand in Oncology (zacks.com)
VAR has been the subject of several analyst reports. Royal Bank of Canada set a $105.00 target price on shares of Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, November 30th. Evercore ISI began coverage on shares of Varian Medical Systems in a report on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 price objective for the company. Goldman Sachs Group lowered shares of Varian Medical Systems from a “neutral” rating to a “sell” rating and set a $98.00 target price for the company. in a research report on Thursday, January 25th. Citigroup raised their price objective on shares of Varian Medical Systems from $128.00 to $132.00 and gave the company a “buy” rating in a research report on Thursday, January 25th. Finally, Barrington Research upgraded shares of Varian Medical Systems from a “market perform” rating to an “outperform” rating and set a $130.00 price objective for the company in a research report on Thursday, January 25th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $111.80.
Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 EPS for the quarter, beating the Zacks’ consensus estimate of $1.00 by $0.06. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The firm had revenue of $678.50 million for the quarter, compared to analysts’ expectations of $633.96 million. During the same quarter in the previous year, the business posted $1.09 EPS. The company’s quarterly revenue was up 12.8% on a year-over-year basis. sell-side analysts forecast that Varian Medical Systems will post 4.31 EPS for the current year.
In other Varian Medical Systems news, EVP Kolleen T. Kennedy sold 699 shares of the business’s stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $126.47, for a total value of $88,402.53. Following the completion of the transaction, the executive vice president now owns 27,361 shares of the company’s stock, valued at approximately $3,460,345.67. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Dow R. Wilson sold 88,766 shares of the company’s stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $111.00, for a total transaction of $9,853,026.00. Following the sale, the insider now directly owns 155,542 shares of the company’s stock, valued at approximately $17,265,162. The disclosure for this sale can be found here. In the last quarter, insiders sold 188,006 shares of company stock worth $21,706,262. 0.78% of the stock is currently owned by company insiders.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.